Refreshing results…
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in Acute Myeloid Leukemia
Download from ashpublications.orgOutcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
UploadMissing publications? Search for publications with a matching author name.